Trial Profile
Pharmacokinetical-clinical study of intravescical gemcitabine in patients with marker lesion of superficial transitional cell carcinoma of the bladder.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2011
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 25 Jul 2011 New trial record